Skip to main content Accessibility help
×
Home
Hostname: page-component-564cf476b6-qp9dn Total loading time: 0.211 Render date: 2021-06-22T15:22:47.780Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Crossover reaction between haloperidol and amoxapine for NMS

Published online by Cambridge University Press:  02 January 2018

Koichi Otani
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital, Hirosaki 036, Japan
Kazuo Mihara
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital, Hirosaki 036, Japan
Motohiro Okada
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital, Hirosaki 036, Japan
Sunao Kaneko
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital, Hirosaki 036, Japan
Yutaka Fukushima
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital, Hirosaki 036, Japan
Rights & Permissions[Opens in a new window]

Abstract

Image of the first page of this article. For PDF version, please use the ‘Save PDF’ preceeding this image.
Type
Columns
Copyright
Copyright © 1991 The Royal College of Psychiatrists 

References

Baca, L. & Martinelli, L. (1990) Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant. Neurology, 40, 17971798.CrossRefGoogle ScholarPubMed
Cohen, B. M., Harris, P. Q., Altesman, R. I., et al (1982) Amoxapine: neuroleptic as well as antidepressant? American Journal of Psychiatry, 139, 11651167.Google ScholarPubMed
Halman, M. & Goldbloom, D. S. (1990) Fluoxetine and neuroleptic malignant syndrome. Biological Psychiatry, 28, 518521.CrossRefGoogle ScholarPubMed
Otani, K., Horiuchi, M., KoNDO, T., et al (1991) is the predisposition to neuroleptic malignant syndrome genetically transmitted? British Journal of Psychiatry, 158, 850853.CrossRefGoogle ScholarPubMed
Rosebush, P. & Stewart, T. (1989) A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 717725.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.
You have Access
16
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Crossover reaction between haloperidol and amoxapine for NMS
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Crossover reaction between haloperidol and amoxapine for NMS
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Crossover reaction between haloperidol and amoxapine for NMS
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *